Guangzhou IGE Biotechnology Co., Ltd.
Guangzhou IGE Biotechnology Co., Ltd.
Guangzhou IGE Biotechnology Co., Ltd.
Guangzhou IGE Biotechnology Co., Ltd.
CRISPR sgRNA libraries
Introduction
CRISPR-Cas9 technology is a powerful tool for gene editing that has revolutionized the field of biology. It allows researchers to precisely and efficiently edit DNA at any desired location. CRISPR sgRNA libraries are a type of CRISPR-Cas9 tool that can be used for high-throughput gene screening.
Service process
Service advantages
Rich experience in gene synthesis and library construction, ensuring the diversity and uniformity of the library, the library can reach 10^8.
Select sgRNA expression vectors according to customer needs and provide transfection-grade plasmids.
Provide a one-stop service from sgRNA design, library construction to lentivirus packaging.
Application cases
Vemurafenib (PLX), a drug used to treat unresectable or metastatic melanoma with BRAF V600 mutations, can be resistant to the drug due to mutations in cancer cells. Scientists are trying to find the gene targets that lead to resistance to BRAF protein kinase inhibitor vemurafenib (PLX) in melanoma. Using A375 cells as a model, GeCKO forward selection was applied to determine the genes that were knocked out and caused resistance, and to develop drugs against new targets.
A：Timeline of PLX resistance screening for A375 melanoma cells
B：Under the condition of exposure to PLX, the transduced A375 cells stop growing, these cells carry V600E functional gain BRAF mutations
Therefore, a small group of cells that have become resistant through Cas9/sgRNA-mediated editing can be enriched. Vehicle is the control group
After 14 days of PLX treatment, the sgRNA distribution was significantly different from that of the control-treated cells (Wilcoxon rank sum test,
P < 10?10), and it was clustered separately from all other conditions.
The authors found a small set of genes that were enriched with multiple sgRNAs targeting each gene after 14 days of PLX treatment,suggesting that the loss of these specific genes helps A375 cells acquire PLX resistance.
Example figure
Shalem Ophir,Sanjana Neville E,Hartenian Ella et al. Genome-scale CRISPR-Cas9 knockout screening in human cells.[J] .Science, 2014, 343: 84-87.
參考文獻(xiàn)
[1] Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelson T, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F.
Genome-scale CRISPR-Cas9 knockout screening in human cells.
Science. 2014 Jan 3;343(6166):84-87. doi: 10.1126/science.1247005. Epub 2013 Dec 12. PMID: 24336571; PMCID: PMC4089965.
[2] Wang Y, Gao B, Tan PY, Handoko YA, Sekar K, Deivasigamani A, Seshachalam VP, OuYang HY, Shi M, Xie C, Goh BKP, Ooi LL, Man Hui K.
Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth.
FASEB J. 2019 Aug;33(8):8759-8770. doi: 10.1096/fj.201802213RR. Epub 2019 Apr 25. PMID: 31022357; PMCID: PMC6662966.
[3] Kiessling M K, Schuierer S, Stertz S, et al.
Identification of oncogenic driver mutations by genome-wide CRISPR-Cas9 dropout screening[J].
BMC genomics, 2016, 17(1): 1-16.
[4] Sasaki M, Ogiwara H.
Synthetic lethal therapy based on targeting the vulnerability of SWI/SNF chromatin remodeling complex‐deficient cancers[J].
Cancer Science, 2020, 111(3): 774-782.
[5] Shen JP, Zhao D, Sasik R, Luebeck J, Birmingham A, Bojorquez-Gomez A, Licon K, Klepper K, Pekin D, Beckett AN, Sanchez KS, Thomas A, Kuo CC, Du D, Roguev A, Lewis NE, Chang AN, Kreisberg JF, Krogan N, Qi L, Ideker T, Mali P.
Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions.
Nat Methods. 2017 Jun;14(6):573-576. doi: 10.1038/nmeth.4225. Epub 2017 Mar 20. PMID: 28319113; PMCID: PMC5449203.
[6] Feng X, Tang M, Dede M, et al.
Genome-wide CRISPR screens using isogenic cells reveal vulnerabilities conferred by loss of tumor suppressors[J].
Science advances, 2022, 8(19): eabm6638.
[7] Zhang R, Miner JJ, Gorman MJ, Rausch K, Ramage H, White JP, Zuiani A, Zhang P, Fernandez E, Zhang Q, Dowd KA, Pierson TC, Cherry S, Diamond MS.
A CRISPR screen defines a signal peptide processing pathway required by flaviviruses.
Nature. 2016 Jul 7;535(7610):164-8. doi: 10.1038/nature18625. Epub 2016 Jun 17. PMID: 27383988; PMCID: PMC4945490.
[8] Ma H, Dang Y, Wu Y, Jia G, Anaya E, Zhang J, Abraham S, Choi JG, Shi G, Qi L, Manjunath N, Wu H.
A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death.
Cell Rep. 2015 Jul 28;12(4):673-83. doi: 10.1016/j.celrep.2015.06.049. Epub 2015 Jul 16. PMID: 26190106; PMCID: PMC4559080.
Copyright ? Guangzhou IGE Biotechnology Co., Ltd.
粵ICP備2021146096號(hào)
?
